Fan, Yue
Zhang, Chenglu
Zhu, Minyi
Xu, Yang
Tang, Haimeng
Pang, Jiaohui
Bao, Hairong
Ou, Qiuxiang
Bao, Hua
Xu, Bei
Funding for this research was provided by:
National Natural Science Foundation of China (82403966)
Chinese Society of Clinical Oncology (Y-2022HER-2AZQN-0382)
Wu JiePing Medical Foundation of China (320.6750.2023-01-15)
Beijing Life Oasis Public Service Center(Beijing Life Oasis Public Service Center) and Bethune Charitable Foundation (YDTR-006)
Article History
Received: 16 September 2025
Accepted: 31 December 2025
First Online: 19 January 2026
Declarations
:
: The study was approved by the Ethics Committee of Zhongshan Hospital of Fudan University (ethical number: 2024-082R). All patients have signed informed consent forms before sample collection and consented to the publication of related clinical information.
: Not applicable.
: Authors M. Zhu, Y. Xu, H. Tang, J. Pang, HR. Bao, Q. Ou and H. Bao are employees of Geneseeq Technology Inc. All other authors declare no conflict of interest.